Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NASDAQ:ZSAN

Zosano Pharma (ZSAN) Stock Price, News & Analysis

Zosano Pharma logo

About Zosano Pharma Stock (NASDAQ:ZSAN)

Advanced Chart

Key Stats

Today's Range
$0.0002
$0.0002
50-Day Range
$0.52
$112.00
52-Week Range
$0.46
$37.45
Volume
5,685 shs
Average Volume
425,375 shs
Market Capitalization
$980.40
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive ZSAN Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Zosano Pharma and its competitors with MarketBeat's FREE daily newsletter.

ZSAN Stock News Headlines

Aktuelle Empfehlungen zur ZOSANO
The Trump Dump is starting; Get out of stocks now?
The first 365 days of the Trump presidency… Will be the best time to get rich in American history.
HOOK HOOKIPA Pharma Inc.
East Bay Business News
Astellas Pharma
Zosano Pharma Corporation (ZSANQ)
See More Headlines

ZSAN Stock Analysis - Frequently Asked Questions

Zosano Pharma Co. (NASDAQ:ZSAN) announced its earnings results on Friday, May, 13th. The biotechnology company reported ($1.76) earnings per share for the quarter, missing the consensus estimate of ($1.75) by $0.01. Zosano Pharma had a negative trailing twelve-month return on equity of 177.06% and a negative net margin of 8,375.11%.

Zosano Pharma's stock reverse split on the morning of Tuesday, April 12th 2022.The 1-35 reverse split was announced on Tuesday, April 12th 2022. The number of shares owned by shareholders was adjusted after the closing bell on Tuesday, April 12th 2022. An investor that had 100 shares of stock prior to the reverse split would have 3 shares after the split.

Zosano Pharma (ZSAN) raised $47 million in an initial public offering on Tuesday, January 27th 2015. The company issued 4,300,000 shares at a price of $10.00-$12.00 per share. Ladenburg Thalmann and Roth Capital Partners acted as the underwriters for the IPO.

Based on aggregate information from My MarketBeat watchlists, some other companies that Zosano Pharma investors own include Tonix Pharmaceuticals (TNXP), NIO (NIO), Adamis Pharmaceuticals (ADMP), Bionano Genomics (BNGO), NightHawk Biosciences (NHWK), Sorrento Therapeutics (SRNE) and Aeterna Zentaris (AEZS).

Company Calendar

Last Earnings
5/13/2022
Today
7/05/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Pharmaceutical Preparations
Sub-Industry
N/A
Current Symbol
NASDAQ:ZSAN
Fax
N/A
Employees
40
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$29.92 million
Net Margins
-8,375.11%
Pretax Margin
-8,375.11%

Debt

Sales & Book Value

Annual Sales
$790 thousand
Price / Cash Flow
N/A
Book Value
$9.74 per share
Price / Book
0.00

Miscellaneous

Free Float
4,784,000
Market Cap
$980.40
Optionable
Not Optionable
Beta
3.30

Social Links

 The Best Nuclear Energy Stocks to Buy Cover

Nuclear energy stocks are roaring. It's the hottest energy sector of the year. Cameco Corp, Paladin Energy, and BWX Technologies were all up more than 40% in 2024. The biggest market moves could still be ahead of us, and there are seven nuclear energy stocks that could rise much higher in the next several months. To unlock these tickers, enter your email address below.

Get This Free Report

This page (NASDAQ:ZSAN) was last updated on 7/6/2025 by MarketBeat.com Staff
From Our Partners